South Korea's Naver jumps 10% on Nvidia's $1 billion investment plan

Oil drops, stock futures surge at the weekly open

FDA Approves Centanafadine for ADHD in Children, Adolescents, and Adults

The FDA has approved Otsuka's Simtriyo (centanafadine), the first new-class ADHD medication for pediatric and adult patients in decades.

Major retailer announces its closing 75 stores, slowing growth plans

Inside the S&P 500 AI boom, industrials are getting as rich as tech stocks

Industrial stocks in the S&P 500 are reaching valuations comparable to tech stocks, fueled by AI data centers and defense technology.

Indonesia central bank chief resigns

The surprise resignation of Bank Indonesia Governor Perry Warjiyo has triggered currency volatility and a transition to acting leadership.

Microsoft's Next Earnings Report on July 29 Could Send the Stock Soaring. Here's Why.